Low adherence to inhaled corticosteroids/long-acting β2-agonists and biologic treatment in severe asthmatics
Marco Caminati, Andrea Vianello, Margherita Andretta, Anna Michela Menti, Silvia Tognella, Luca Degli Esposti, Claudio Micheletto, Chiara Bovo, Gianenrico Senna
ERJ Open Research 2020 6: 00017-2020; DOI: 10.1183/23120541.00017-2020
Marco Caminati
1Asthma Center and Allergy Unit, Verona University and General Hospital, Verona, Italy
2Dept of Medicine, University of Verona, Verona, Italy
Andrea Vianello
3Respiratory Pathophysiology Division, University-City Hospital of Padua, Padua, Italy
Margherita Andretta
4Health Technology Assessment Unit, Azienda Zero, Padua, Italy
Anna Michela Menti
4Health Technology Assessment Unit, Azienda Zero, Padua, Italy
Silvia Tognella
5Respiratory Unit, Orlandi General Hospital, Verona, Italy
Luca Degli Esposti
6CliCon S.r.l. Health, Economics and Outcomes Research, Ravenna, Italy
Claudio Micheletto
7Cardio-Thoracic Dept, Respiratory Unit, Integrated University Hospital, Verona, Italy
Chiara Bovo
8Medical Direction, University Hospital of Verona, Verona, Italy
Gianenrico Senna
1Asthma Center and Allergy Unit, Verona University and General Hospital, Verona, Italy
Vol 6 Issue 2
Table of Contents
Low adherence to inhaled corticosteroids/long-acting β2-agonists and biologic treatment in severe asthmatics
Marco Caminati, Andrea Vianello, Margherita Andretta, Anna Michela Menti, Silvia Tognella, Luca Degli Esposti, Claudio Micheletto, Chiara Bovo, Gianenrico Senna
ERJ Open Research Apr 2020, 6 (2) 00017-2020; DOI: 10.1183/23120541.00017-2020
Low adherence to inhaled corticosteroids/long-acting β2-agonists and biologic treatment in severe asthmatics
Marco Caminati, Andrea Vianello, Margherita Andretta, Anna Michela Menti, Silvia Tognella, Luca Degli Esposti, Claudio Micheletto, Chiara Bovo, Gianenrico Senna
ERJ Open Research Apr 2020, 6 (2) 00017-2020; DOI: 10.1183/23120541.00017-2020